Insigneo Advisory Services LLC Buys 754 Shares of The Allstate Corporation $ALL

Insigneo Advisory Services LLC increased its stake in shares of The Allstate Corporation (NYSE:ALL) by 67.7% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,867 shares of the insurance provider’s stock after purchasing an additional 754 shares during the period. Insigneo Advisory Services LLC’s holdings in Allstate were worth $376,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in ALL. Arlington Trust Co LLC lifted its holdings in shares of Allstate by 261.8% in the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after buying an additional 89 shares in the last quarter. Clearstead Trust LLC increased its holdings in Allstate by 3,800.0% during the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 152 shares during the period. Caitong International Asset Management Co. Ltd lifted its stake in Allstate by 315.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after purchasing an additional 126 shares in the last quarter. Hilltop National Bank bought a new position in Allstate in the 2nd quarter valued at $34,000. Finally, Chilton Capital Management LLC purchased a new position in shares of Allstate during the 2nd quarter valued at $38,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 0.6%

Shares of NYSE ALL opened at $213.92 on Thursday. The stock has a market capitalization of $55.98 billion, a P/E ratio of 10.06, a PEG ratio of 0.69 and a beta of 0.35. The Allstate Corporation has a one year low of $176.00 and a one year high of $215.89. The firm’s 50 day simple moving average is $204.37 and its two-hundred day simple moving average is $202.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.

Allstate (NYSE:ALL) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The company had revenue of $17.26 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same quarter in the prior year, the company earned $3.91 EPS. The firm’s revenue was up 3.8% on a year-over-year basis. As a group, analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Allstate Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 1.9%. The ex-dividend date is Monday, December 1st. Allstate’s dividend payout ratio is presently 12.95%.

Insider Activity

In other news, insider Suren Gupta sold 21,871 shares of Allstate stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $215.21, for a total value of $4,706,857.91. Following the transaction, the insider owned 100,646 shares in the company, valued at approximately $21,660,025.66. The trade was a 17.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 24,271 shares of company stock worth $5,222,986 over the last quarter. 1.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ALL has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. increased their price objective on Allstate from $254.00 to $260.00 and gave the stock an “overweight” rating in a research report on Thursday, November 6th. Cantor Fitzgerald upgraded Allstate to a “hold” rating in a research note on Wednesday, August 13th. BMO Capital Markets lifted their price target on Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Wolfe Research raised shares of Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Finally, Wall Street Zen downgraded shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Saturday, November 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $237.92.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.